[Effect of treatment with encorton and cytostatics on cellular immunity in patients with systemic lupus erythematosus].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002648:Child; D004359:Drug Therapy, Combination; D006801:Humans; D007958:Leukocyte Count; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000276:immunology; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000276:immunology*; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage*; D012397:Rosette Formation
D000970:Antineoplastic Agents; D011241:Prednisone
Wpływ leczenia enkortonem i cytostatykami na odporność komórkowa u chorych na toczeń rumieniowaty układowy.